Gender-Affirming Care in a Transgender Young Woman With Li-Fraumeni Syndrome: A Case Report

J Pediatr Health Care. 2024 Mar-Apr;38(2):270-274. doi: 10.1016/j.pedhc.2023.10.005.

Abstract

The number of youths who identify with a gender different from their sex designated at birth is increasing. Youth account for about 4% of all cancer diagnoses in the United States. Some youths may want gender-affirming medical treatment, such as puberty blockers and/or hormone therapy, which may exacerbate cancer and/or increase cancer development risk. No studies assess the impact of estrogen-based treatment in gender-diverse youth with a history of Li-Fraumeni syndrome. This case report will discuss gender-affirming care and shared decision-making in a youth with a history of Li-Fraumeni syndrome and increased risk for breast cancer.

Keywords: Gender-affirming care; Li-Fraumeni syndrome; adolescent; breast cancer; young adult.

Publication types

  • Case Reports

MeSH terms

  • Female
  • Gender-Affirming Care
  • Humans
  • Li-Fraumeni Syndrome* / diagnosis
  • Li-Fraumeni Syndrome* / therapy
  • Puberty Inhibitors
  • Transgender Persons*
  • Young Adult

Substances

  • Puberty Inhibitors